Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: Edwards CLASP TR EFS [NA]

View source ↗

Summary

Edwards Lifesciences reports completed results from the CLASP TR EFS trial evaluating its transcatheter therapy for tricuspid regurgitation, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLASP TR

Snippet

Sponsor: Edwards Lifesciences | Conditions: Tricuspid Regurgitation | NA | Status: COMPLETED | Results posted: 2024-10-09